Tuesday, February 13, 2024

BuPa raises a $20m VC find for Healthtech Companies

Adelle Moynihan’s  work over the last five months at Bupa, building Bupa Ventures, has come to life through launch in the The Australian Financial Review 😊 
 
Yes, it takes a minute to build a corporate venture fund, and I have learnt that's for good reason. Behind the scenes, the Ventures team has been aligning Bupa's robust capabilities to be able to deliver value beyond capital to the health techs we fund. 
 
In the words of CEO Nick Stone 
 
"That's the hardest thing for any start-up, getting a customer base. We can offer a readymade one as well as a very well capitalised business to support their growth".
 
Here's a fund overview for you
- $20m to deploy with an allocation for follow-on
- Seed - Series A stage
- Backing APAC companies
- Strategic fund with a focus on predictive and preventative healthcare, genomics and personalised medicine, and in-home and remote monitoring solutions. 
- Value beyond capital with a partner that is one of the worlds few, truly global, healthcare provisioners

Health techs, start applying! 



No comments: